| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |